Seronegative spondyloarthropathy / Spondyloarthritis can cause inflammatory back pain, sacroiliac pain, morning stiffness, tendon pain, joint symptoms, fatigue, and overlapping chronic pain patterns, even when standard rheumatoid arthritis markers are negative.
Seronegative spondyloarthropathies are a group of inflammatory conditions that can cause chronic joint pain, stiffness, and reduced mobility, even when standard blood tests are negative. Dr. Nino explains how these conditions are diagnosed and the personalized treatment options available to help reduce inflammation and improve function.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
If you have been dealing with chronic back pain, stiffness, joint pain, or inflammatory symptoms, but your lab work keeps coming back normal, it may be worth looking at a group of conditions called seronegative spondyloarthropathies. These are inflammatory autoimmune conditions that commonly affect the spine, peripheral joints, tendons, and connective tissue. Seronegative means that the classic biomarkers may not show up in the blood, even though significant inflammation is still present. Conditions in this group include things like ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and inflammatory arthritis associated with inflammatory bowel disease.
Patients often experience symptoms like morning stiffness, back or SI joint pain, fatigue, peripheral joint pain or swelling, and enthesitis pain, or pain that improves with movement but worsens with prolonged rest or inactivity. One of the challenges is that many patients are told that their pain is mechanical or muscular for years before the inflammatory pattern is recognized.
Treatment focuses on controlling inflammation early, protecting joints and mobility, reducing pain, and improving long-term function. Depending on the patient, that may include physical therapy, anti-inflammatory medications, biologic therapies, movement-based treatment, and coordinated care across specialties. If you have been struggling with chronic stiffness, inflammatory pain, or symptoms that seem to flare throughout the body, we’re here to help you better understand what may be contributing and what treatment options may help.
Seronegative spondyloarthropathy refers to a group of inflammatory arthritis conditions that can affect the spine, sacroiliac joints, tendons, entheses, and peripheral joints. These conditions may cause inflammatory back pain, morning stiffness, SI joint pain, heel pain, tendon pain, joint swelling, fatigue, and symptoms that overlap with psoriasis, bowel inflammation, eye inflammation, or other immune-related conditions.
The term “seronegative” means that standard rheumatoid arthritis markers, such as rheumatoid factor, may be negative. This does not mean the pain is not inflammatory. Some patients have symptoms that strongly suggest an inflammatory arthritis process despite negative or inconclusive labs.
At Manhattan Pain Medicine (MPM), evaluation begins with the pain pattern, not a single lab result. For patients looking for seronegative spondyloarthropathy treatment in Manhattan or NYC, MPM helps distinguish inflammatory spine and joint pain from mechanical back pain, facet-mediated pain, sacroiliac joint dysfunction, hypermobility-related pain, central pain syndromes, small fiber neuropathy, and other overlapping contributors.
MPM evaluates seronegative spondyloarthropathy-related pain through a diagnosis-first lens. This includes reviewing pain timing, morning stiffness, response to movement or rest, SI joint symptoms, spine involvement, tendon or heel pain, peripheral joint symptoms, inflammatory history, autoimmune symptoms, prior imaging, lab results, medication response, and prior rheumatology evaluation.
MPM does not replace rheumatology. When immune-directed treatment such as DMARDs, biologics, or infusion therapy may be appropriate, coordination with rheumatology is essential. MPM’s role is to help identify pain generators, assess mechanical and inflammatory overlap, support medication management when appropriate, and consider image-guided options such as sacroiliac joint injection or steroid injections only when the diagnosis and pain pattern support them.
Inflammatory back pain can be mistaken for routine mechanical back pain, posture-related pain, SI joint dysfunction, facet arthropathy, muscle tightness, or hypermobility-related pain. Many patients are treated with physical therapy, injections, massage, or anti-inflammatory medication without a clear explanation for why pain keeps returning.
One clue is the pattern. Inflammatory back pain often develops gradually, may be worse in the morning or after rest, may improve with movement, and may be associated with prolonged stiffness. Patients may also have heel pain, tendon pain, joint swelling, fatigue, psoriasis, bowel symptoms, or eye inflammation.
MPM evaluates these patterns carefully. The goal is not to label every back pain case as autoimmune, but to identify when inflammation may be part of the picture and when rheumatology coordination is needed.
Seronegative spondyloarthropathy fits within MPM’s Autoimmune and Inflammatory, Musculoskeletal issues, and Complex Chronic Pain frameworks. In some patients, pain is primarily inflammatory. In others, inflammatory disease coexists with mechanical spine pain, sacroiliac dysfunction, hypermobility, EDS, HSD, small fiber neuropathy, or central pain syndromes.
MPM evaluates these relationships carefully. The goal is to identify what is inflammatory, what is mechanical, what is neurologic, and what may be part of a broader chronic pain process. This helps guide appropriate coordination with rheumatology, physical therapy, imaging specialists, primary care, and other clinicians.
These guys are the best. I've been going here for over 6 years and their familiarity with my Schwannomatosis (most ppl have never even heard of it - its rather rare) and their ability to diagnose my CRPS quickly and accurately and then treat it like I was merely getting a flu shot is just incredible...
Highly recommended for those who need Pain Management. Everyone at Manhattan Pain Medicine is extremely nice and helpful. I have had very good interactions with both Dr. Siefferman and Dr. Louis. All of the staff is very responsive. 5 stars.
The providers at Manhattan Pain Medicine are exceptional. I wish I had found them 30 years ago!
I genuinely can’t say enough good things about the team at Manhattan Pain Medicine. I have MCAS, EDS, and an inflammatory autoimmune disease, and I’ve basically been searching for answers since I was a kid. I had years of unexplained inflammation markers, chronic pain, and allergic reactions despite...
I have a complex medical history and have seen a lot of doctors over the years. Dr. Mikaberidze and Dr. Siefferman each took the time to really listen and understand everything I had been dealing with. I also appreciated how they work together and communicated about my care. I left with a plan that...
Sharing my gratitude for the pleasant experience last week during my visit, the medical team provided great care and also treated my session as a learning experience, I left my session with a wealth of knowledge. A big thank you to the kind, and professional staff who welcomed me to the office as a...
I cannot say enough good things about Manhattan Pain Medicine. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional — knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
Dr Siefferman is the most thorough, patient doctor I have even been to. Currently I travel from miami to nyc to see him because his bed side manner and desire to help is incomparable.
ZocDoc
This practice is wonderful. I have been a patient of Dr. Siefferman’s since 2019 and he’s extremely helpful and kind. He has brought in a Rheumatologist who is also great. They handle very complex pain issues and always try to find new ways to help me.
Dr. Siefferman is an incredible doctor! He is extremely diligent and knowledgeable. It feels like you are his only patient. He invests a lot of time and effort into your injuries and concerns. I did not find these wonderful qualities with other pain specialists before, who were always rushed and som...
ZocDoc
Dr. Siefferman is a doctor who combines the old world bedside manner of doctors from my childhood (60 years ago) with a sta te of the art embrace of modern technology. It is always a pleasure to have an appointment with him...always has options and solutions to my medical issues. He is truly the doc...
ZocDoc
Dr. Siefferman is a genius. He is very informed and listens attentively.
ZocDoc
Dr. Siefferman and his entire team continue to be efficient, dedicated, and driven by precision and a genuine desire to give fantastic care. Will always recommend.
ZocDoc
Doctor Siefferman is fantastic. Have been seeing him for 5 years. Couldn’t recommend more.
ZocDoc
Dr. Siefferman is the ONLY doctor who has ever been able to diagnose my pain and treat it. He is hands down the best
ZocDoc
Seronegative spondyloarthropathy is a term used for a group of inflammatory arthritis conditions that can affect the spine, sacroiliac joints, tendons, entheses, and peripheral joints. These conditions may cause inflammatory back pain, morning stiffness, SI joint pain, tendon pain, heel pain, joint swelling, fatigue, and symptoms involving the eyes, skin, or gastrointestinal system.
The terms are closely related. Spondyloarthritis is often used as the broader modern term for this family of inflammatory conditions. Seronegative spondyloarthropathy emphasizes that the condition may occur without positive rheumatoid factor or other classic rheumatoid arthritis markers. The category can include axial spondyloarthritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and arthritis associated with inflammatory bowel disease.
“Seronegative” means that certain blood markers commonly associated with rheumatoid arthritis, such as rheumatoid factor, are negative. This does not rule out inflammatory arthritis. Some patients with inflammatory spine, SI joint, tendon, or joint symptoms have negative rheumatoid arthritis markers and may still require rheumatology evaluation.
Yes. Seronegative spondyloarthropathy can cause inflammatory back pain, especially in the lower back, buttock region, sacroiliac joints, or spine. Pain may be worse after rest or in the morning and may improve with movement. Back pain should still be evaluated carefully because similar symptoms can come from disc disease, facet arthropathy, SI joint dysfunction, hypermobility, muscle pain, infection, fracture, or neurologic causes.
Inflammatory back pain is a pattern of back pain that may develop gradually, cause prolonged morning stiffness, feel worse after rest, and improve with movement or exercise. It may occur with fatigue, alternating buttock pain, SI joint pain, tendon pain, heel pain, psoriasis, bowel symptoms, or eye inflammation. It is different from typical mechanical back pain, although both can coexist.
Yes. The sacroiliac joints are commonly involved in axial spondyloarthritis and related inflammatory conditions. Inflammation of the SI joints is called sacroiliitis. Patients may feel pain in the low back, buttocks, hips, pelvis, or upper legs. MPM evaluates whether SI joint pain appears inflammatory, mechanical, hypermobility-related, or mixed.
Yes. Spondyloarthropathy can involve the entheses, which are areas where tendons or ligaments attach to bone. This is called enthesitis. It may cause heel pain, Achilles tendon pain, plantar fascia pain, hip tendon pain, rib pain, or other tendon attachment pain. Enthesitis can be mistaken for simple overuse or tendinopathy if the inflammatory pattern is not recognized.
Yes. HLA-B27 can be associated with axial spondyloarthritis and ankylosing spondylitis, but not every patient with spondyloarthropathy is HLA-B27 positive. A negative HLA-B27 test does not automatically rule out the condition. Diagnosis depends on the full clinical picture, including symptoms, exam findings, imaging, labs, family history, and rheumatology assessment.
Diagnosis is usually made through a combination of history, physical examination, symptom pattern, imaging, lab work, inflammatory markers, HLA-B27 testing when appropriate, and rheumatology evaluation. Imaging may include X-ray or MRI of the sacroiliac joints or spine when inflammatory disease is suspected. MPM helps evaluate the pain pattern and coordinates with rheumatology when immune-directed diagnosis or treatment is needed.
Treatment depends on the specific diagnosis, disease activity, pain generators, and functional impact. Care may include rheumatology-directed medication, DMARDs or biologics when appropriate, medication management, physical therapy or movement-based strategies, acupuncture, Feldenkrais, biofeedback, steroid injections, sacroiliac joint injection, infusions, or chronic pain support. Image-guided procedures are considered only when the pain pattern and diagnosis support them.
DMARDs or biologics may be considered when rheumatology determines that immune-directed treatment is appropriate for inflammatory arthritis. These medications are not pain procedures and should be managed by clinicians experienced in inflammatory disease treatment. MPM may coordinate with rheumatology while supporting pain generator evaluation, medication review, function-focused care, and selected pain interventions when appropriate.
Back or joint pain should be evaluated urgently if it is associated with fever, unexplained weight loss, history of cancer, severe night pain, new weakness or numbness, bowel or bladder dysfunction, saddle anesthesia, major trauma, eye pain or vision changes, chest pain, shortness of breath, rapidly worsening symptoms, or signs of infection. Eye pain, redness, or vision changes can be especially important in inflammatory arthritis and should be evaluated promptly.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
Seronegative spondyloarthropathy is a family of inflammatory arthritis conditions that can involve the spine, sacroiliac joints, peripheral joints, tendons, and entheses. These conditions are often discussed under the broader term spondyloarthritis. They may include axial spondyloarthritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and arthritis associated with inflammatory bowel disease.
The word “seronegative” can be confusing. It does not mean that symptoms are not real or that inflammation is not possible. It means that certain rheumatoid arthritis-related blood markers, such as rheumatoid factor, may be negative. Some patients with inflammatory back pain, sacroiliitis, enthesitis, tendon pain, or peripheral joint symptoms may still have a spondyloarthropathy even when standard labs are inconclusive.
One of the most important distinctions is whether pain behaves like inflammatory pain, mechanical pain, or both. Mechanical back pain often worsens with activity, lifting, posture, strain, or specific movements. Inflammatory back pain may be worse after rest, worse in the morning, associated with prolonged stiffness, and improve with movement.
This difference matters because the treatment path may be very different. Mechanical spine pain may involve the discs, facet joints, sacroiliac joints, muscles, tendons, ligaments, or nerves. Inflammatory spine pain may require rheumatology evaluation, immune-directed medication, imaging for sacroiliitis, and long-term inflammatory disease monitoring.
The sacroiliac joints are a common site of pain in spondyloarthropathy. Inflammatory sacroiliitis can cause pain in the lower back, buttocks, hips, pelvis, or upper legs. Mechanical SI joint dysfunction can create similar symptoms, especially in patients with hypermobility, pelvic mechanics issues, or prior injury.
MPM evaluates whether SI joint pain appears inflammatory, mechanical, instability-related, referred from the spine, or part of a broader chronic pain pattern. This distinction helps determine whether care should prioritize rheumatology-directed treatment, image-guided SI joint evaluation, movement-based care, or a combination of approaches.
Spondyloarthropathy can affect the entheses, where tendons and ligaments attach to bone. This can cause heel pain, Achilles pain, plantar fascia pain, hip tendon pain, rib pain, shoulder pain, or other tendon attachment symptoms. Patients may also have joint swelling, stiffness, or pain in the knees, ankles, hips, shoulders, wrists, or hands.
These symptoms are often treated as isolated tendonitis, overuse, or orthopedic pain. In some patients, that explanation is correct. In others, tendon pain may be part of a broader inflammatory pattern. MPM evaluates the full picture, including whether tendon pain appears mechanical, inflammatory, hypermobility-related, or mixed.
Seronegative spondyloarthropathy can be missed when symptoms are treated only as mechanical pain. A patient may have years of low back pain, SI joint pain, heel pain, tendon pain, or morning stiffness before inflammatory arthritis is considered. Negative rheumatoid factor, normal early X-rays, or fluctuating symptoms can add to the confusion.
MPM’s approach is designed to avoid that kind of oversimplification. Evaluation considers pain timing, stiffness, movement response, imaging, inflammatory symptoms, family history, autoimmune history, prior medication response, and overlapping pain generators.
Not every patient with spondyloarthropathy has only inflammatory pain. Some patients also have hypermobility spectrum disorder, Ehlers-Danlos syndrome, fibromyalgia, central pain syndromes, small fiber neuropathy, or autonomic symptoms. These overlapping conditions can make pain more widespread, more persistent, or less responsive to a single treatment.
This is why MPM evaluates both inflammatory and non-inflammatory contributors. A patient may need rheumatology-directed care for inflammatory disease and pain medicine support for SI joint dysfunction, facet-mediated pain, neuropathic symptoms, chronic pain sensitization, or function-limiting pain patterns.
MPM begins by reviewing the full symptom history. This includes the location of pain, onset, morning stiffness, rest and movement patterns, night pain, tendon pain, heel pain, joint swelling, fatigue, eye symptoms, skin symptoms, bowel symptoms, imaging results, lab history, medication trials, and prior rheumatology or spine care.
The evaluation may also include physical examination, spine and SI joint assessment, movement testing, imaging review, medication review, and consideration of diagnostic or image-guided procedures when appropriate. When symptoms suggest active inflammatory disease, MPM coordinates with rheumatology for diagnostic confirmation and immune-directed treatment planning.
Treatment depends on the specific diagnosis and the dominant pain drivers. Rheumatology-directed care may include anti-inflammatory medication, DMARDs, biologics, or infusion-based therapy when clinically appropriate. These treatments require specialist evaluation and monitoring.
Pain-focused care may include medication management, movement-based strategies, acupuncture, Feldenkrais, biofeedback, steroid injections, sacroiliac joint injection, or other image-guided options when the pain generator supports that approach. Regenerative medicine, ketamine therapy, lidocaine and ketamine infusions, or other advanced options should not be considered routine treatments for spondyloarthropathy and require careful patient selection.
Seronegative spondyloarthropathy can affect multiple systems and may overlap with other pain conditions. A coordinated plan may involve rheumatology, pain medicine, physical therapy, primary care, gastroenterology, ophthalmology, dermatology, neurology, or other specialists depending on symptoms.
MPM’s role is to help clarify the pain pattern, identify treatable pain generators, support function, and coordinate next steps. This is especially important when symptoms have been dismissed because labs were negative or when pain persists despite prior injections, physical therapy, or medication trials.
Patients should seek urgent evaluation for fever, unexplained weight loss, history of cancer, severe night pain, new neurologic deficits, bowel or bladder dysfunction, saddle anesthesia, major trauma, eye pain or vision changes, chest pain, shortness of breath, rapidly worsening symptoms, or signs of infection. These symptoms may indicate conditions that require immediate medical attention and should not be treated as routine inflammatory back pain.
MPM approaches seronegative spondyloarthropathy through diagnosis-first care. The goal is to determine whether symptoms reflect inflammatory arthritis, mechanical spine pain, sacroiliac dysfunction, facet-mediated pain, hypermobility-related pain, small fiber neuropathy, central pain syndromes, or a combination of contributors.
For patients looking for seronegative spondyloarthropathy treatment in Manhattan or NYC, MPM offers a coordinated pain medicine perspective focused on inflammatory pattern recognition, pain generator mapping, rheumatology coordination, and individualized treatment planning.
